project id: TCGA-LUAD; case submitter id: TCGA-50-5944; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; spectrophotometer method: UV Spec; age at index: 69; days to birth: -25440; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1941; age at diagnosis: 25440; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1750.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8550/3; primary diagnosis: Acinar cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 0.6; longest dimension: 0.6; preservation method: Unknown; shortest dimension: 0.2; sample id: bf8fdf82-62b4-4b5d-93e7-ce153576fe49; sample submitter id: TCGA-50-5944-01A; portion id: 6ec4fc54-1b0d-4d29-a393-b75057c76a88; portion submitter id: TCGA-50-5944-01A-11; slide id: f05f3c1f-13eb-48fe-b6fa-55c426792f17; slide submitter id: TCGA-50-5944-01A-01-TS1; percent lymphocyte infiltration: 7.0; percent monocyte infiltration: 7.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP;